Wound care

Continued innovation through Mepilex Border Heel

By: Mölnlycke Health Care, September 5 2013Posted in: Wound care

 

The well established and highly successful product range of Mepilex® Border continues to grow and innovate. Working together with healthcare professionals and patients, Mölnlycke Health Care has developed Mepilex® Border Heel – a new advanced bordered dressing specifically shaped for the management of wounds located on the heel. Mepilex Border Heel will enable healthcare professionals to reduce costs thanks to the benefits of the unique 5-layer absorbent foam structure consisting of Safetac® technology, and the dressing’s fit-for-purpose shape, which eliminates the need for additional fixation.

Mepilex Border Heel is the latest addition to the Mepilex Border range of dressings with Safetac technology. Safetac is the adhesive layer of the dressing, which gently adheres to the skin without sticking to moist surfaces, minimising damage to the wound and the surrounding skin by sealing the wound margins and thereby preventing exudate from escaping1,2,3. This protects the newly formed tissue and promotes natural healing benefitting both patients and healthcare organisations alike by minimising trauma and pain, allowing for optimised healing, which will result in lower costs.

The heel is the second-most likely location (after the sacrum) to develop pressure ulcers4,5. Due to its shape, managing wounds on the heel often proves difficult and sometimes requires the clinician to custom-cut dressings. Mepilex Border Heel is the perfect solution, providing the necessary adhesive capability to allow for greater patient mobility while at the same time reducing the need for additional dressing changes.

 
Heel wounds are protected from outside pressure, friction and shear, thanks to the dressing's stability, making Mepilex Border Heel ideal for treating and preventing pressure ulcers. The two-part foam pad, consisting of the 5-layer absorbent foam structure, redistribute shear and pressure, reduce friction, and maintain an optimal microclimate.
 
The original Mepilex Border, the first bordered foam dressing with Safetac technology, was launched in 2001 and has since become a well established and highly successful product range worldwide. Mepilex® Border Sacrum launched in 2007 was the first dressing in the product range with a dedicated anatomical shape for the sacrum. Mepilex Border Heel is the latest addition to the range together with Mepilex® Border Flex.

 

References

  1. Meaume S. et al. A study to compare a new self adherent soft silicone dressing with a self adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Management, 2003.  
  2. Feili F et al. Retention capacity. Poster presentation at the EWMA conference, Lisbon, Portugal 2008. 
  3. Wiberg A.B. et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster presented at the 3rd Congress of the WUWHS, Toronto, Canada, 2008. 
  4. Results of nine international pressure ulcer surveys: 1989-2005. Ostomy Wound Management; 54(2). Vangilder C et al; 2008.
  5. Prospective Pilot Study of Atypical PU Presentation in a Skilled geriatric Nursing Unit; Jaul E et al Ostomy Wound Manage. 2011 Feb.
Share this

More from the same category

Mextra Superabsorbent

Our new Superabsorbent Wound care dressing is here! Its design is based on a unique 4-layer construction...

Meet us at EWMA 23-25 May 2012 in Vienna

We exhibit at EWMA as Corporate A Sponsors to show how our wide range of...

Ask the Experts about about the role...

Some of the world’s leading experts will take part in an outstanding symposium...

Mölnlycke Health Care acquires innovative...

Mölnlycke Health Care announces that it has acquired a pioneering electrical...

Mölnlycke Health Care Wound care - Exhibits...

Mölnlycke Health Care will take part in World Union of Wound Healing Societies...

Molnlycke.com now offers even more knowledge...

We are proud to present “Ask the experts”, the latest feature in the Knowledge...

Join us or follow us online during WUWHS...

We look forward to meeting you at the World Union of Wound Healing Societies...

WUWHS 2012 is now open!

From today the 3rd of Sept until the 6th of Sept Mölnlycke Health Care will be delighted to meet...

Dr Evan Call on the difference between...

On the 3rd of September Mölnlycke Health Care, together with some of the...

Wendy White on the topic pain as a universal...

On the 5th of September Mölnlycke Health Care, together with some of the...

Do you know about Stop Pressure Ulcer...

This annual day aims to raise awareness of the global burden of pressure...

Stop Pressure Ulcers

Did you know that Stop Pressure Ulcer Awareness Day is happening this Friday 16 November? This...

EWMA pressure ulcer symposium report:...

The EWMA delegates who attended the Mölnlycke Health Care seminar on pressure...

Mepilex Transfer Ag

The efficacy of wound contact layer dressings with antimicrobial properties in clinical wound care...

Mepilex Border Post-Op

The need for a reliable, surgically safe post-operative wound dressing for both clinical and patient...

EWMA 2013

EWMA 2013 in Copenhagen, Denmark, is set to become the best-attended wound care conference ever...

Introducing Mepilex Border Flex

The Mepilex® Border product range has just become more versatile than...

Mölnlycke Health Care welcomes you to...

Every day we will "share our care" by presenting you different views on...

Construction matters: The use of multilayer...

During this year's World Union congress in Yokohama, Japan C Tod Brindle...

Mepilex Ag - A key element in wound...

A recently published French study has confirmed the effectiveness of Mepilex®...

EWMA symposium report: Examining how...

Several hundred EWMA delegates attended the Mölnlycke Health Care symposium,...

International DEBRA Congress 2013

Epidermolysis bullosa (EB) is a rare, inherited skin disorder which causes...

Mölnlycke Health Care presents pain...

Mölnlycke Health Care participated in two interesting congresses in Vienna,...

Mölnlycke Health Care proud sponsor...

Mölnlycke Health Care recently had the honour of sponsoring the 2013 DEBRA...

Clinical trial shows dressings have...

Hospital acquired pressure ulcers are a major challenge for medical practitioners....

ISPeW congress 2013

It is approximately one week until the inter-annual  ISPeW meeting in Miami, US. The International...

EWMA 2014

Mölnlycke Health Care has always been creating a legacy of leading the way in wound care management,...

Influencing cost effective wound care

Mölnlycke Health Care has chosen "Leading the way in innovation and evidence"...

Study showing that Mepitel Film prevents...

Radiation-induced skin reactions occur in 80-90 percent of breast cancer...

Summarizing EWMA 2014 in Madrid

As in previous years, delegates who attended the EWMA 2014 Conference in...

EPUAP conference 2014

Mölnlycke Health Care will participate as corporate sponsors at EPUAP (European Pressure Ulcer Advisory...

ISBI congress 2014

This month, Mölnlycke Health Care has been attending, hosting dedicated events and been platinum...

EWMA 2015

One of the best showcases for innovation is in the sharing of knowledge and best practices, and...

EWMA 2015 recap

The annual European Wound Management Association (EWMA) event gives Mölnlycke Health Care the opportunity...

GlucanPro 3000 and GlucanPro Cream changing...

Mölnlycke Health Care has announced that it will no longer offer GlucanPro®...

Proven prevention: Proof into practice...

Hospital acquired conditions, such as pressure ulcers, are expensive and,...

Mepilex Border Post-Op wins Health Product...

Mölnlycke Health Care is proud to announce that Mepilex® Border Post-Op has...

New pressure ulcer prevention monograph...

Hospital-acquired conditions are a strategic focus area for Mölnlycke Health...